Stocktoria
Trulieve Cannabis Corp. TRLV
Trulieve Cannabis Corp. financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.1B | $1.2B | $931.9M | $521.5M |
| Gross profit | $711.2M | $715.7M | $588.6M | $689.1M | $566.6M | $386.4M |
| SG&A expense | $445.2M | $510.5M | $386.2M | — | — | — |
| Operating income | $143.5M | $97.8M | -$221.6M | $50.2M | $204.1M | $218.3M |
| Interest expense | — | — | $81.6M | $73.4M | $29.1M | $20.2M |
| Income tax | $208.1M | $197.6M | $151.4M | $163.4M | $145.7M | $94.5M |
| Net income | — | — | — | -$252.7M | $17.4M | $63.0M |
| EPS (diluted) | $-0.58 | $-0.79 | $-2.28 | $-0.95 | $0.21 | $0.53 |
| Operating cash flow | $272.8M | $271.5M | $201.8M | $23.1M | $12.9M | $99.6M |
| Free cash flow | $228.6M | $148.9M | $161.6M | -$141.7M | -$263.0M | -$298,000 |
| Cash & equivalents | $255.5M | $238.8M | $201.4M | $207.2M | $226.6M | $146.7M |
| Inventory | $242.3M | $231.4M | $213.1M | $276.5M | $209.9M | $98.3M |
| Total assets | $2.7B | $2.9B | $2.7B | $3.4B | $3.4B | $809.8M |
| Total liabilities | $1.6B | $1.6B | $1.3B | $1.5B | $1.3B | $361.9M |
| Shareholders' equity | $1.1B | $1.2B | $1.4B | $1.9B | $2.1B | $447.9M |
Growth · year-over-year · Revenue CAGR 17.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue growth | -0.4% | +5.1% | -7.3% | +30.7% | +78.7% | — |
| Net income growth | — | — | — | -1548.7% | -72.3% | — |
| EPS growth | — | — | — | -552.4% | -60.4% | — |
| Free cash flow growth | +53.6% | -7.9% | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.